Tufts University School of Medicine’s Biopharma Program, is designed specifically to enhance career options through intensive training in disciplines that contribute to the development and regulation of human pharmaceuticals and medical devices. This specialized program meets a critical need for structured, educational opportunities that have a focus on the fundamental concepts of therapeutic product development.
The Biopharma Program’s academic offerings include a master’s degree and a certificate track, and are tailored to the needs of working professionals who want to attend classes on a part-time basis in the evening. The master’s degree consists of twelve credits to be completed over two academic years, and includes didactic coursework as well as an experiential capstone project. The five-credit certificate is a twelve-month program comprised of core discipline courses taken in lock-step with the master's degree track.
The Tufts Biopharma Program is closely aligned with the activities of Tufts Center for the Study of Drug Development (CSDD), the internationally recognized and renowned academic center that develops and provides strategic information to help developers, regulators, and policy makers improve the efficiency and productivity of biomedical innovation.
The Boston and Cambridge metropolitan area surrounding Tufts University School of Medicine is a unique life sciences “super cluster” with numerous pharmaceutical, biotechnology, device, and diagnostics companies. Nestled among top-ranked academic research centers, contract services provider organizations, and venture capital, intellectual property, and investment firms, Tufts is an ideal location to study biopharma.